{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T04:17:23Z","timestamp":1744431443270,"version":"3.40.4"},"reference-count":12,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":5691,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1017\/s1041610209008667","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T09:42:35Z","timestamp":1236159755000},"page":"576-580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Attitudes of old age psychiatrists in England and Wales to the use of mood stabilizer drugs"],"prefix":"10.1016","volume":"21","author":[{"given":"E.","family":"Ephraim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Prettyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2007","series-title":"Psychotropic Drug Directory 2007","author":"Bazire","key":"10.1017\/S1041610209008667_bb0010"},{"key":"10.1017\/S1041610209008667_bb0015","unstructured":"Committee on Safety of Medicines (2006). New Advice Issued on Risperidone and Olanzapine: Press Release. Available at http:\/\/www.mhra.gov.uk; last accessed 3 December 2007."},{"key":"10.1017\/S1041610209008667_bb0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/bmb\/57.1.179","article-title":"Developments in mood stabilizers, depression and public health","volume":"57","author":"Ferrier","year":"2001","journal-title":"British Medical Bulletin"},{"key":"10.1017\/S1041610209008667_bb0025","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1365-2125.2005.02507.x","article-title":"Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics","volume":"61","author":"Grimm","year":"2006","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1017\/S1041610209008667_bb0030","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00004714-199504000-00010","article-title":"Hypothesized interaction between valproic acid and warfarin","volume":"15","author":"Guthrie","year":"1995","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1017\/S1041610209008667_bb0035","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0893-133X(98)00019-0","article-title":"Lithium: early development, toxicity and renal function","volume":"19","author":"Johnson","year":"1998","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl. 1","key":"10.1017\/S1041610209008667_bb0040","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/1099-1166(200112)16:1+<::AID-GPS564>3.0.CO;2-Y","article-title":"Psychotropics and drug interactions in the elderly patient","volume":"16","author":"Katona","year":"2001","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610209008667_bb0045","unstructured":"National Institute for Health and Clinical Excellence (2002). Clinical Guideline 1: Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. Available at http:\/\/www.nice.org.uk\/guidance; last accessed 7 December 2007."},{"key":"10.1017\/S1041610209008667_bb0050","unstructured":"National Institute for Health and Clinical Excellence (2007). Clinical Guideline 23 (amended): Depression: Management of Depression in Primary and Secondary Care. Available at http:\/\/www.nice.org.uk\/guidance; last accessed 7 December 2007."},{"issue":"10","key":"10.1017\/S1041610209008667_bb0055","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/gps.1784","article-title":"Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia","volume":"22","author":"Sajatovic","year":"2005","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610209008667_bb0060","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/bmj.326.7396.960","article-title":"Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence","volume":"326","author":"Shulman","year":"2003","journal-title":"BMJ"},{"key":"10.1017\/S1041610209008667_bb0065","first-page":"297","article-title":"Telephone versus postal surveys of general practitioners: methodological considerations","volume":"44","author":"Sibbald","year":"1994","journal-title":"British Journal of General Practice"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224057661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224057661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610209008667","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T18:09:01Z","timestamp":1744394941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224057661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S1041610224057661"],"URL":"https:\/\/doi.org\/10.1017\/s1041610209008667","relation":{},"ISSN":["1041-6102"],"issn-type":[{"type":"print","value":"1041-6102"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attitudes of old age psychiatrists in England and Wales to the use of mood stabilizer drugs","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610209008667","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Copyright \u00a9 International Psychogeriatric Association 2009. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}